STK11 and lung carcinoma: Consistently, we have previously found that Lkb1 inactivation is able to drive lung cancer AST in the KrasG12D-based genetically engineered mouse models (GEMM).23,27–29 These pathologically transitioned mouse tumors also display therapeutic resistance to multiple inhibitors initially effective in lung ADC,29 similar to the clinical observations.